The Department of Justice’s reclassification of certain marijuana products from Schedule I to Schedule III marks a significant shift in federal drug policy, and employers are now facing new questions about how to respond. In this installment of our Workplace Strategies Watercooler 2026 podcast series, shareholders Christina Mallatt (Indianapolis) and Tae Phillips (Birmingham), who co-chair the firm’s Drug Testing practice group, are joined by Phillip Russell (Tampa) to examine what the change means for workplace drug testing programs, ADA accommodation obligations, and the broader landscape of cannabis-related employment policies. Tune in for practical guidance on how employers can evaluate and update their policies in light of this evolving regulatory environment.

Transcript

Transcript Pending

Share Podcast


A man is pruning cannabis plants in the foreground, wearing gloves, and is visible from elbows to fingers. There are others in the background working.
Practice Group

Drug Testing

Ogletree Deakins understands that employers face complex and nuanced issues when implementing and enforcing drug and alcohol testing and substance abuse policies. Drawing on decades of experience advising and defending drug testing laboratories, and public and private employers across the country and internationally, our attorneys provide highly responsive legal service

Learn more
Businessmen walking and talking in empty warehouse
Practice Group

Workplace Safety and Health

The Occupational Safety and Health (OSH) practice of Ogletree Deakins is characterized by the knowledge and credibility of our attorneys, and the exceptional level of service that we provide to our clients.

Learn more

Sign up to receive emails about new developments and upcoming programs.

Sign Up Now